Noema Pharma
Biotech company targeting debilitating central nervous system (CNS) disorders
Basel, Switzerlandnoemapharma.com ↗
Total raised
€135M
€135,192,758
Funding rounds
2
Investors
7
distinct backers
Active since
2023-03
latest 2024-12
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood49
base rate 48% for Series B
- ▲ In typical raise window
- ▼ Down/flat last round
Exit likelihood17
base rate 12% (2+ rounds)
- ▲ €100M+ raised
Timing: in window vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-12-11 | Series B | €29M | Forbion,Gilde Healthcare,Invus,Jeito Capital,Polaris Partners,Sofinnova Partners+1 more | View deal → |
| 2023-03-07 | Series B | €106M | Forbion,Gilde Healthcare,Invus,Jeito Capital,Polaris Partners,Sofinnova Partners+1 more | View deal → |
Investors
7Related news
- Noema Pharma Raises USD112M in Series B Financingfinsmes.com · 2023-03
- startupticker.ch
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Climeworks€920MSwitzerland · Cleantech
- Energy Vault€896MSwitzerland · Energy